ArticleBioscience reports2018

Evaluation of efficacy and safety of Reteplase and Alteplase in the treatment of hyper-acute cerebral infarction.

Zhi-Jian Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.